Publications

Project publications

In this section you will be informed about publications from the project.

Reports about the project

Bundesministerium für Familie, Senioren, Frauen und Jugend (2023). Gemeinsam für Menschen mit Demenz. Zur Halbzeit der Nationalen Demenzstrategie, Berlin. PDF.

Relevant publications by the project members

  • Wilhelm, C., Steckelberg, A., & Rebitschek, F. G. (2025). Is Artificial Intelligence Beneficial for the Patients? A Systematic Review on Algorithmic Decision Support for Medical Professionals. The Lancet: Regional Health Europe, 48, 101145. DOI: 10.1016/j.lanepe.2024.101145 .
  • Karneboge, J., Haberstroh, J., Geschke, K., Perry, J., Radenbach, K., Jessen, F., & Rostamzadeh, A. (2024). Facing the new diagnostic and treatment options of Alzheimer’s disease: The necessity of informed consent. Alzheimer’s & Dementia: The journal of the Alzheimer’s Association, 21(1). DOI: 10.1002/alz.14204
  • Perry, J., Radenbach, K., Geschke, K., & Rostamzadeh, A. (2024). Counseling and disclosure practices in predictive Alzheimer’s disease diagnostics: A scoping review. Alzheimer’s & Dementia: The journal of the Alzheimer’s Association, 20(12), 8910–8936. DOI: 10.1002/alz.14365
  • Schicktanz, S., Alpinar-Segawa, Z., Ulitsa, N., Perry, J., & Werner, P. (2024). Moving Towards Ethical-Practical Recommendations for Alzheimer’s Disease Prediction: Addressing Interindividual, Interprofessional, and Societal Aspects. Journal of Alzheimer’s disease : JAD, 101(4), 1063–1081. DOI: 10.3233/JAD-231137
  • Perry, J., Brose, J., & Radenbach, R. (2023). Well Advised: The Need for Counseling in Early Stages of Alzheimer’s Disease. GeroPsych, 36(4), 189–202. DOI: 10.1024/1662-9647/a000318
  • Boccardi, M., Dodich, A., Albanese, E., Gayet-Ageron, A., Festari, C., Ashton, NJ., Bischof, GN., Chiotis, K., Leuzy, A., Wolters, EE., Walter, MA., Rabinovici, GD., Carrillo, M., Drzezga, A., Hansson, O., Nordberg, A., Ossenkoppele, R., Villemagne, VL., Winblad, B., Frisoni, GB., Garibotto, V. (2021). The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers: methodological update. Eur J Nucl Med Mol Imaging, 48(7). 2070-2085. DOI: 10.1007/s00259-020-05120-2
  • Lohmeyer, L.J., Alpinar-Sencan, Z., Schicktanz, S. (2021). Attitudes Towards Prediction and Early Diagnosis of Late-Onset Dementia: A Comparison of Tested Persons and Family Caregivers, Aging Mental Health, 25(5), 832-843. DOI: 10.1080/13607863.2020.1727851
  • Boccardi, M., Nicolosi, V., Festari, C., Bianchetti, A., Cappa, S., Chiasserini, D., Falini, A., Guerra, UP., Nobili, F., Padovani, A., Sancesario, G., Morbelli, S., Parnetti, L., Tiraboschi, P., Muscio, C., Perani, D., Pizzini, FB, Beltramello, A., Salvini Porro, G., Ciaccio, M., Schillaci, O., Trabucchi, M., Tagliavini, F., Frisoni, GB. (2020). Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patients. Eur J Neurol., 27(3), 475-483. DOI: 10.1111/ene.14117
  • Katsikopoulos, K. V., Șimșek, Ö., Buckmann, M., & Gigerenzer, G. (2020). Classification in the wild: The science and art of transparent decision making. MIT Press. DOI: 10.7551/mitpress/11790.001.0001
  • Schicktanz, S., Perry, J., Herten, B., Stock Gissendanner, S. (2020). Demenzprädiktion als ethische Herausforderung: Stakeholder fordern Beratungsstandards für Deutschland. Nervenarzt. DOI: 10.1007/s00115-020-00985-y
  • Rebitschek, F. G., Reisel, D., Lein, I., & Wegwarth, O. (2019). Epigenetic Risk Assessment of Female Cancers: Women‘s Information Needs and Attitudes. Public Health Genomics, 22(1-2), 46-57. DOI: 10.1159/000501975
  • Wegwarth, O., Pashayan, N., Widschwendter, M., & Rebitschek, F. G. (2019). Women’s perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online survey. BMC Public Health, 19(1), 667. doi: 10.1186/s12889-019-6994-8
  • Wöhlke, S., Schaper, M., Schicktanz, S. (2019). How Uncertainty Influences Lay People’s Attitudes and Risk Perceptions Concerning Predictive Genetic Testing and Risk Communication. Frontiers in genetics, 10, 380. DOI: 10.3389/fgene.2019.00380
  • Bartels, C., Wagner, M., Wolfsgruber, S., Ehrenreich, H., Schneider, A., Alzheimer’s Disease Neuroimaging (2018). Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer’s Dementia in Individuals With Previous Depression. The American journal of psychiatry, 175(3). 232-241. DOI: 10.1176/appi.ajp.2017.17040404
  • Porteri, C., Albanese E., Scerri, C., Carrillo, MC., Snyder, HM., Martensson, B., Baker, M., Giacobini, E., Boccardi, M, Winblad, B., Frisoni GB., Hurst, S., Geneva Task Force for the Roadmap of Alzheimer’s Biomarkers (2017). The biomarker-based diagnosis of Alzheimer’s disease. 1-ethical and societal issues. Neurobiol Aging., 52, 132-140. DOI: 10.1016/j.neurobiolaging.2016.07.011
  • McDowell, M., Rebitschek, F. G., Gigerenzer, G., & Wegwarth, O. (2016). A Simple Tool for Communicating the Benefits and Harms of Health Interventions: A Guide for Creating a Fact Box. MDM Policy & Practice, 1(1). DOI: 10.1177/2381468316665365
  • Gigerenzer, G., & Muir Gray, J. A. (Eds.). (2011). Better doctors, better patients, better decisions: Envisioning health care 2020. Cambridge, MA: MIT Press. DOI: 10.1093/scipol/sct037